Drug Shortage Report for RATIO-ATORVASTATIN
Report ID | 2343 |
Drug Identification Number | 02350335 |
Brand name | RATIO-ATORVASTATIN |
Common or Proper name | ATORVASTATIN |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-04-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-12-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-14 | English | Compare |
v2 | 2017-03-14 | French | Compare |
v3 | 2017-03-14 | English | Compare |
v4 | 2017-03-14 | French | Compare |
v5 | 2017-04-02 | English | Compare |
v6 | 2017-04-25 | English | Compare |
v7 | 2017-04-25 | French | Compare |
v8 | 2017-05-08 | English | Compare |
v9 | 2017-05-08 | French | Compare |
v10 | 2017-07-27 | English | Compare |
v11 | 2017-07-27 | French | Compare |
v12 | 2017-09-05 | English | Compare |
v13 | 2017-09-05 | French | Compare |
Showing 1 to 13 of 13